Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers<sup></sup>.

Khalique, Saira; Nash, Sarah; Natrajan, Rachael

Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers.

Khalique, Saira; Nash, Sarah; Natrajan, Rachael.

Afiliação

Khalique S; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, London, UK.
Nash S; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, London, UK.
Natrajan R; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, London, UK.

J Pathol ; 258(1): 1-3, 2022 09.

Article em En | MEDLINE | ID: mdl-35647895

Assuntos

Carcinoma Endometrioide; Endometriose; Neoplasias Ovarianas; Carcinoma Endometrioide/patologia; Proteínas de Ligação a DNA/genética; Endometriose/genética; Feminino; Humanos; Mutação; Proteínas Nucleares/genética; Proteínas Nucleares/metabolismo; Neoplasias Ovarianas/patologia; Fatores de Transcrição/genética

Palavras-chave

ARID1A; CD8 tumour infiltrating lymphocytes; biomarker; endometriosis-associated ovarian carcinomas; mismatch repair deficiency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Endometrioide / Endometriose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Pathol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google